Time-restricted feeding reduces adiposity in mice fed a high-fat diet

Nutrition Research

Volumn 36, Issue 6, 2016, Pages 603-611

  Sundaram, Sneha ^a   Yan, Lin ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Ad libitum; Adiposity; High fat diet; Mice; Time restricted feeding

Indexed keywords

ADIPONECTIN; GHRELIN; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; CCL2 PROTEIN, MOUSE; LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CARBON DIOXIDE TENSION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIET RESTRICTION; ENERGY EXPENDITURE; FAT MASS; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIGHT DARK CYCLE; LIPID DIET; LUNG GAS EXCHANGE; MALE; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT GAIN; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; DISEASE MODEL; ENERGY METABOLISM; TIME FACTOR;

ADIPOSITY; ANIMALS; BODY WEIGHT; CHEMOKINE CCL2; CIRCADIAN RHYTHM; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GHRELIN; INSULIN; LEPTIN; MALE; MICE; MICE, INBRED C57BL; OBESITY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84983681037     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.02.005     Document Type: Article

References (42)

1. [1] Froy, O., Circadian rhythms and obesity in mammals. ISRN Obes, 2012, 2012, 437198.
2. [2] Mattson, M.P., Allison, D.B., Fontana, L., Harvie, M., Longo, V.D., Malaisse, W.J., et al. Meal frequency and timing in health and disease. Proc Natl Acad Sci U S A 111 (2014), 16647–16653.
3. [3] Arble, D.M., Bass, J., Laposky, A.D., Vitaterna, M.H., Turek, F.W., Circadian timing of food intake contributes to weight gain. Obesity 17 (2009), 2100–2102.
4. [4] Jaakkola, J., Hakala, P., Isolauri, E., Poussa, T., Laitinen, K., Eating behavior influences diet, weight, and central obesity in women after pregnancy. Nutrition 29 (2013), 1209–1213.
5. [5] Sherman, H., Genzer, Y., Cohen, R., Chapnik, N., Madar, Z., Froy, O., Timed high-fat diet resets circadian metabolism and prevents obesity. Faseb J 26 (2012), 3493–3502.
6. [6] Turek, F.W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., McDearmon, E., et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science 308 (2005), 1043–1045.
7. [7] Chaix, A., Zarrinpar, A., Miu, P., Panda, S., Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab 20 (2014), 991–1005.
8. [8] Zvonic, S., Ptitsyn, A.A., Conrad, S.A., Scott, L.K., Floyd, Z.E., Kilroy, G., et al. Characterization of peripheral circadian clocks in adipose tissues. Diabetes 55 (2006), 962–970.
9. [9] Wardlaw, S.L., Burant, C.F., Klein, S., Meece, K., White, A., Kasten, T., et al. Continuous 24-hour leptin, proopiomelanocortin, and amino acid measurements in human cerebrospinal fluid: correlations with plasma leptin, soluble leptin receptor, and amino acid levels. J Clin Endocrinol Metab 99 (2014), 2540–2548.
10. [10] Hatori, M., Vollmers, C., Zarrinpar, A., DiTacchio, L., Bushong, E.A., Gill, S., et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab 15 (2012), 848–860.
11. [11] Zhang, Y., Daquinag, A., Traktuev, D.O., Amaya-Manzanares, F., Simmons, P.J., March, K.L., et al. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 69 (2009), 5259–5266.
12. [12] Anderson, J.W., Konz, E.C., Frederich, R.C., Wood, C.L., Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 74 (2001), 579–584.
13. [13] Haas, M.C., Bodner, E.V., Brown, C.J., Bryan, D., Buys, D.R., Keita, A.D., et al. Calorie restriction in overweight seniors: response of older adults to a dieting study: the CROSSROADS randomized controlled clinical trial. J Nutr Gerontol Geriatr 33 (2014), 376–400.
14. [14] Riebe, D., Greene, G.W., Ruggiero, L., Stillwell, K.M., Blissmer, B., Nigg, C.R., et al. Evaluation of a healthy-lifestyle approach to weight management. Prev Med 36 (2003), 45–54.
15. [15] Varady, K.A., Bhutani, S., Church, E.C., Klempel, M.C., Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr 90 (2009), 1138–1143.
16. [16] Kohsaka, A., Laposky, A.D., Ramsey, K.M., Estrada, C., Joshu, C., Kobayashi, Y., et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 6 (2007), 414–421.
17. [17] Reeves, P.G., Nielsen, F.H., Fahey, G.C.J., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993), 1939–1951.
18. [18] Institute for Laboratory Animal Research, Guide for the care and use of laboratory animals. 8th ed., 2011, National Academies Press, Washington, D.C.
19. [19] Weir, J.B., New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109 (1949), 1–9.
20. [20] Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M.S., Suganuma, T., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 (2000), 4255–4261.
21. [21] Cummings, D.E., Purnell, J.Q., Frayo, R.S., Schmidova, K., Wisse, B.E., Weigle, D.S., A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001), 1714–1719.
22. [22] Christiansen, T., Richelsen, B., Bruun, J.M., Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29 (2005), 146–150.
23. [23] Kralisch, S., Bluher, M., Tonjes, A., Lossner, U., Paschke, R., Stumvoll, M., et al. Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. Eur J Endocrinol 156 (2007), 257–261.
24. [24] Virtue, S., Vidal-Puig, A., Assessment of brown adipose tissue function. Front Physiol, 4, 2013, 128.
25. [25] Speakman, J.R., Measuring energy metabolism in the mouse—theoretical, practical, and analytical considerations. Front Physiol, 4, 2013, 34.
26. [26] Dulloo, A.G., Girardier, L., Adaptive changes in energy expenditure during refeeding following low-calorie intake: evidence for a specific metabolic component favoring fat storage. Am J Clin Nutr 52 (1990), 415–420.
27. [27] Williams, K.W., Scott, M.M., Elmquist, J.K., From observation to experimentation: leptin action in the mediobasal hypothalamus. Am J Clin Nutr 89 (2009), 985S–990S.
28. [28] Yan, L., Graef, G.L., Claycombe, K.J., Johnson, L.K., Effects of voluntary running and soy supplementation on diet-induced metabolic disturbances and inflammation in mice. J Agric Food Chem 61 (2013), 9373–9379.
29. [29] Fenton, J.I., Nunez, N.P., Yakar, S., Perkins, S.N., Hord, N.G., Hursting, S.D., Diet-induced adiposity alters the serum profile of inflammation in C57BL/6N mice as measured by antibody array. Diabetes Obes Metab 11 (2009), 343–354.
30. [30] Pajvani, U.B., Hawkins, M., Combs, T.P., Rajala, M.W., Doebber, T., Berger, J.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279 (2004), 12152–12162.
31. [31] Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001), 941–946.
32. [32] Sartipy, P., Loskutoff, D.J., Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100 (2003), 7265–7270.
33. [33] Takahashi, K., Mizuarai, S., Araki, H., Mashiko, S., Ishihara, A., Kanatani, A., et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 278 (2003), 46654–46660.
34. [34] Wang, H., Chen, Y., Lu, X.A., Liu, G., Fu, Y., Luo, Y., Endostatin prevents dietary-induced obesity by inhibiting adipogenesis and angiogenesis. Diabetes 64 (2015), 2442–2456.
35. [35] Maquoi, E., Munaut, C., Colige, A., Collen, D., Lijnen, H.R., Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51 (2002), 1093–1101.
36. [36] Chavey, C., Mari, B., Monthouel, M.N., Bonnafous, S., Anglard, P., Van Obberghen, E., et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278 (2003), 11888–11896.
37. [37] Alexander, C.M., Selvarajan, S., Mudgett, J., Werb, Z., Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol 152 (2001), 693–703.
38. [38] Selzman, C.H., Miller, S.A., Zimmerman, M.A., Gamboni-Robertson, F., Harken, A.H., Banerjee, A., Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol 283 (2002), H1455–H1461.
39. [39] Streblow, D.N., Soderberg-Naucler, C., Vieira, J., Smith, P., Wakabayashi, E., Ruchti, F., et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99 (1999), 511–520.
40. [40] Hong, K.H., Ryu, J., Han, K.H., Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105 (2005), 1405–1407.
41. [41] Yamada, M., Kim, S., Egashira, K., Takeya, M., Ikeda, T., Mimura, O., et al. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 23 (2003), 1996–2001.
42. [42] Corn Refiners Association, Corn oil. 2006, 1–22 [ http://www.corn.org/wp-content/uploads/2009/12/CornOil.pdf].